His research interests focus on understanding basic underlying mechanisms of
ocular angiogenesis and identifying therapeutic
approaches to treating neovascular eye
diseases such as macular degeneration and diabetic retinopathy.
In particular, widespread
ocular diseases such as age - related macular degeneration (AMD) and retinitis pigmentosa (RP), as well as a genetic condition called Stargardt's macular dystrophy (STGD) that afflicts young people, are all potential
disease targets for therapeutic
approaches.